Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oropharyngeal Colostrum for Infection Prevention in VLBW Infants
NCT02912585Completed
- Sponsor
- Universidade Federal de Uberlândia
- Start
- Jul 2013
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised, double-blind trial of colostrum in sepsis (3 arms), sponsored by Universidade Federal de Uberlândia. Primary endpoints: Incidence of late-onset sepsis at 3 months and Measurement of immunologic factors in urine and blood at 3 months. Started Jul 2013; status: completed.
02
Drugs
colostrum
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02912585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02912585.